MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs

Author(s)
Pepper, L. R.; Cortese, J. F.; Estiu, G.; Galinsky, K.; Zuzarte-Luis, V.; Derbyshire, E. R.; Ribacke, U.; Lukens, A. K.; Santos, S. A.; Patel, V.; Clish, C. B.; Sullivan, W. J.; Zhou, H.; Bopp, S. E.; Schimmel, P.; Clardy, J.; Mota, M. M.; Keller, T. L.; Whitman, M.; Wiest, O.; Wirth, D. F.; Mazitschek, R.; Lindquist, Susan; Herman, Jonathan D.; ... Show more Show less
Thumbnail
DownloadLindquist_The cytoplasmic.pdf (1.191Mb)
OPEN_ACCESS_POLICY

Open Access Policy

Creative Commons Attribution-Noncommercial-Share Alike

Terms of use
Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/
Metadata
Show full item record
Abstract
The emergence of drug resistance is a major limitation of current antimalarials. The discovery of new druggable targets and pathways including those that are critical for multiple life cycle stages of the malaria parasite is a major goal for developing next-generation antimalarial drugs. Using an integrated chemogenomics approach that combined drug resistance selection, whole-genome sequencing, and an orthogonal yeast model, we demonstrate that the cytoplasmic prolyl–tRNA (transfer RNA) synthetase (PfcPRS) of the malaria parasite Plasmodium falciparum is a biochemical and functional target of febrifugine and its synthetic derivative halofuginone. Febrifugine is the active principle of a traditional Chinese herbal remedy for malaria. We show that treatment with febrifugine derivatives activated the amino acid starvation response in both P. falciparum and a transgenic yeast strain expressing PfcPRS. We further demonstrate in the Plasmodium berghei mouse model of malaria that halofuginol, a new halofuginone analog that we developed, is active against both liver and asexual blood stages of the malaria parasite. Halofuginol, unlike halofuginone and febrifugine, is well tolerated at efficacious doses and represents a promising lead for the development of dual-stage next-generation antimalarials.
Date issued
2015-05
URI
http://hdl.handle.net/1721.1/105581
Department
Harvard University--MIT Division of Health Sciences and Technology; Massachusetts Institute of Technology. Department of Biology
Journal
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Herman, J. D. et al. “The Cytoplasmic Prolyl-tRNA Synthetase of the Malaria Parasite Is a Dual-Stage Target of Febrifugine and Its Analogs.” Science Translational Medicine 7.288 (2015): 288ra77-288ra77.
Version: Author's final manuscript
ISSN
1946-6234
1946-6242

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.